{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Agios Pharmaceuticals, Inc."},"Symbol":{"label":"Symbol","value":"AGIO"},"Address":{"label":"Address","value":"88 SIDNEY STREET, CAMBRIDGE, Massachusetts, 2139, United States"},"Phone":{"label":"Phone","value":"+1 617 649-8600"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Agios Pharmaceuticals Inc is a biopharmaceutical company with a focus on developing treatments geared towards cancer and rare genetic disorders of metabolism. The company's primary focus is to develop potentially transformative small-molecule medicines. The clinical development strategy for Agios' product candidates includes a precision approach with initial study designs that allow for genetically or biomarker-defined patient populations. The company seeks the potential for proof of concept early in clinical development, along with any potential for accelerated approval."},"CompanyUrl":{"label":"Company Url","value":"https://www.agios.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Brian M. Goff","title":"Chief Executive Officer &amp; Director"},{"name":"Clive Patience","title":"Executive Vice President-Technical Operations"},{"name":"Sarah Gheuens","title":"Chief Medical Officer, Head-Research &amp; Development"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}